Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 70518-0122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 70518-0122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is information regarding a medication called DULoxetine in the form of delayed-release 60 mg capsules. The prescription contains 90 capsules and is to be used as directed. The medication is manufactured by Breckenridge in Boca Raton, FL. It should be stored at a temperature between 20-25°C (58-77°F). Make sure to keep this medication out of reach of children. For further details, refer to the package insert.*
FDA Label Image

Chemical Structure (Duloxetine 01)

Chemical Structure (Duloxetine 01)
FDA Label Image

Figure 1 (Duloxetine 02)

Figure 1 (Duloxetine 02)
This is a chart showing the proportion of patients experiencing a relapse over time. It compares the relapse rates between a placebo group and a group taking a drug named Dulcolax (dolayocrakasa capsiles). The chart suggests that the group taking the drug has a lower relapse rate compared to the placebo group.*
FDA Label Image

Figure 2 (Duloxetine 03)

Figure 2 (Duloxetine 03)
This text provides information on the proportion of patients with relapse over a specific timeline for a study comparing a placebo with Duloxetine delayed-release capsules. The data shows the number of patients experiencing relapse at different time points in the study.*
FDA Label Image

Figure 3 (Duloxetine 04)

Figure 3 (Duloxetine 04)
FDA Label Image

Figure 4 (Duloxetine 05)

Figure 4 (Duloxetine 05)
FDA Label Image

Figure 5 (Duloxetine 06)

Figure 5 (Duloxetine 06)
FDA Label Image

Figure 6 (Duloxetine 07)

Figure 6 (Duloxetine 07)
Not available.*
FDA Label Image

Figure 7 (Duloxetine 08)

Figure 7 (Duloxetine 08)
FDA Label Image

Figure 8 (Duloxetine 09)

Figure 8 (Duloxetine 09)
FDA Label Image

Figure 9 (Duloxetine 10)

Figure 9 (Duloxetine 10)
Percentage of Patients Improved. Percent Improvement in Pain from Baseline (BOCF).*
FDA Label Image

Figure 10 (Duloxetine 11)

Figure 10 (Duloxetine 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.